Guardant Health Snags $30M For Tumor Sequencing

Redwood City-based Guardant Health has raised $30M in a Series B funding, to go towards development of a no-invasive, tumor sequencing test. The funding was led by Khosla Ventures, and also included Sequoia Capital and Perjman Mar Ventures. Guardant Health is led by Helmy Eltoukhy, and is aimed at diagnosing cancer. More information »